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Abstract Low back pain (LBP) is the most prevalent health
problem in Switzerland and a leading cause of reduced work
performance and disability. This study estimated the total
cost of LBP in Switzerland in 2005 from a societal perspec-
tive using a bottom-up prevalence-based cost-of-illness
approach. The study considers more cost categories than are
typically investigated and includes the costs associated with a
multitude of LBP sufferers who are not under medical care.
The findings are based on a questionnaire completed by a
sample of 2,507 German-speaking respondents, of whom
1,253 suffered from LBP in the last 4 weeks; 346 of them
were receiving medical treatment for their LBP. Direct costs
of LBP were estimated at €2.6 billion and direct medical
costs at 6.1% of the total healthcare expenditure in
Switzerland. Productivity losses were estimated at €4.1 bil-
lion with the human capital approach and €2.2 billion with
the friction cost approach. Presenteeism was the single most
prominent cost category. The total economic burden of LBP
to Swiss society was between 1.6 and 2.3% of GDP.
Keywords Low back pain  Cost-of-illness 
Switzerland  Human capital  Friction cost  Presenteeism
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Introduction
Low back pain (LBP) is the most prevalent health problem
in Switzerland. A large population survey carried out in
Switzerland in 2007 revealed that 47% of women and 39%
of men had suffered from various back problems in the
preceding 4 weeks; this represented the highest prevalence
of all the major health problems surveyed (Swiss Federal
Office of Statistics [9]).
To our knowledge no studies have assessed the eco-
nomic consequences of LBP in Switzerland from a societal
perspective. This was the aim of the present study.
Studies that estimate the economic burden of disease are
known as cost-of-illness (COI) studies [23, 36]. While
some COI studies are limited to the costs accruing to
insurance companies or the public healthcare system, in the
case of LBP a societal perspective is of particular interest,
because it considers the costs incurred by the individuals
affected and the productivity losses for the economy. It is
likely that these costs represent an important share of the
economic burden of LBP since self-help is a frequent
management strategy for LBP and a large number of
workdays are lost to LBP [24].
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In a recent systematic review Dageneais et al. [14]
located 27 relevant studies published between 1997 and
2007 on the cost of LBP in industrialized countries (see
Maetzel and Li [30] and Asche et al. [1] for earlier reviews).
The methodology, cost components considered, and defi-
nition of LBP differed considerably from study to study.
Only 9 studies had considered direct costs as well as pro-
ductivity losses, and the number of direct cost categories
included varied between 4 and 10. All studies that had
considered productivity losses had taken into account
absenteeism due to sick leave, but only a few had consid-
ered early retirement, presenteeism (reduction of produc-
tivity whilst still being at work), and lost productivity in the
household (e.g. child care, cleaning, and cooking). Presen-
teeism makes up the greatest proportion of the overall costs
in many recurrent or chronic conditions [12, 20].
Cost-of-illness studies can be incidence-based or preva-
lence-based and follow a top-down or a bottom-up approach
[39]. In line with most COI studies, in the present study we
adopt a prevalence-based approach, which is considerably
easier to implement as it simply records the costs accruing due
to a disease within a given time span, usually one year.
Contrary to most COI studies, we adopt a bottom-up approach,
which permits the measurement of costs with great detail and
includes out-of-pocket expenses and non-medical direct costs,
which cannot be captured in top-down studies [45].
Our study is based on a very broad data collection that
includes 15 direct cost categories and 3 productivity loss
categories. It includes costs that are not usually considered,
such as expenditure for utility devices (e.g. mattresses,
chairs), physical training, alternative medicine, and assis-
tance in activities of daily living (ADL) by professionals,
family, or friends, all of which are often not reimbursed by
the health insurance provider [16]. These costs may be
particularly important because many of the individuals
affected are not under professional medical treatment [44].
The information collected thus allows a thorough assess-
ment of the true costs of LBP.
Materials and methods
Our study is primarily based on a large survey carried out
using a self-administered questionnaire in the German-
speaking part of Switzerland in 2005. Additional cost
information was collected using a weekly pain diary and a bi-
monthly cost diary administered over a 12-month period in a
subsample of the respondents to the main questionnaire.
Selection of participants
In 2003 the MEM Center of the University of Berne carried
out a major population-based musculoskeletal health
survey with a questionnaire sent to 23,673 German-
speaking individuals over the age of 18 of which 16,634
(70.3%) returned it. The prevalence of LBP in the previous
4 weeks was 24.3%. The present study was nested in this
cross-sectional sample and participants were randomly
selected after primarily stratifying for the presence of LBP
according to the responses to the 2003 survey and a short
telephone interview in 2004.
Questionnaires
The main questionnaire consisted of 260 standardized,
closed questions covering the sociodemographic charac-
teristics of the respondents, their health status, and the
following LBP-specific items: presence and frequency of
LBP, reasons for LBP, pain medication, pain intensity, use
of healthcare services because of LBP, prevention activi-
ties, limitations in ADL, need for assistance, absence from
work and reduced productivity at work, disability pension,
and beliefs regarding LBP [33].
The weekly pain diary consisted of 10 standardized,
closed questions covering pain intensity and frequency, use
of medical resources (pain medication, visits to the general
practitioner, physiotherapist and other therapists), absence
from work, reduced productivity at work, and reduced
abilities in leisure activities. The bi-monthly cost diary
contained 37 open and closed questions covering the use of
medical resources, prevention activities, absence from
work, use of utility devices, and other expenses.
Most of the items in the questionnaires were taken from
previous population-based surveys and had been previously
validated. The item regarding visits to the general practi-
tioner, for example, was validated by Patel et al. [35], and
the item on self-reported absenteeism due to illness by
Severens et al. [41]. Questions regarding healthcare utili-
zation, absenteeism, and presenteeism were in part derived
from the PRODISQ questionnaire [27] validated on
employer data. The primary reference time-frame of ‘‘in
the last 4 weeks’’ was shorter than that used in most other
surveys and was expected to ensure high reliability of the
answers [43].
Direct costs
The questionnaire covered a vast array of direct medical
cost elements associated with the treatment of LBP (see
Table 1), such as visits to the general practitioner and
specialists, different types of therapy, pain medication,
surgery, inpatient hospital stays, and expenditure for utility
devices and physical training connected with the treatment
and prevention of LBP. Basic health insurance is com-
pulsory for every Swiss resident (‘Grundversicherung’). In
2005, approximately 85 public health insurance companies
456 S. Wieser et al.
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(‘Krankenkassen’) were entitled to provide this uniform
‘health benefit basket’. The insurance providers are
financed by individual insurance premiums. All insurers
together form the Association of Swiss Health Insurance
Companies (sante´suisse), which negotiates fees and rates of
reimbursement on their behalf.1
The equivalent costs of outpatient medical visits and
outpatient physiotherapy sessions, as well as average daily
rates for inpatient hospitalization, surgery, inpatient reha-
bilitation, and outpatient hospital visits were provided by
the datapool of sante´suisse. For details see also the last
column in Table 1.
The consumption of pharmaceuticals was estimated on
the basis of the weighted average of quantities recorded by
LBP sufferers in a cost diary. From that, the prices for
medicines were calculated according to the Swiss drug
price compendium. The smallest package size has been
taken as the basis, considering that in outpatient care
approximately 85% of LBP sufferers purchase analgesic
medications over the counter (OTC), and these are avail-
able to the public in small package size only. In inpatient
care, costs for pharmaceuticals are included in the daily fee
anyway.
An important non-medical direct cost covered by the
questionnaire was ‘‘assistance in ADL by professionals,
family or friends’’. Respondents who needed assistance in
the last 4 weeks due to LBP were asked to report the type
and number of hours of assistance received. The price of
€14.60/h for such assistance was derived from a recent
study estimating a shadow price by Scho¨n-Bu¨hlmann et al.
[40] on behalf of the Swiss Federal Office of Statistics.
Productivity losses
The measurement of productivity losses, often also called
indirect costs, is a particularly controversial issue. Most
studies apply the human capital (HC) approach, which
measures productivity losses by multiplying the work-time
lost as a consequence of illness by the gross earnings of the
individuals affected. Some authors have suggested that the
HC approach overestimates the productivity losses to
society [15, 29]. The friction cost (FC) approach, in con-
trast, limits productivity losses to the time-span the
employer needs to restore the initial production level, i.e.
until the sick worker has been replaced [25, 28]. This time-
span is called the friction period. As the FC method limits
the productivity losses to the short run, these estimates are
usually much lower than those made using the HC
approach. In our study, we estimate productivity losses
according to both modalities.
The following causes of productivity loss due to LBP
were considered: absenteeism (temporary absence from
work), presenteeism (reduced productivity of employees
still at work despite illness), and permanent disability. The
questionnaire contained two questions regarding absen-
teeism (‘‘Were you absent from work in the last 4 weeks
because of your back pain?’’ yes or no; if yes, how many
days?) and two questions on presenteeism (‘‘Was your
work productivity in the last week impaired by your back
pain?’’ yes/no; if yes, how much was your productivity
impaired due to your back pain? 10 equal categories, from
10% to 100%), adapted slightly from similar questionnaires
[18, 27]. Self-reported reduced productivity owing to
musculoskeletal symptoms has been assessed in this way
among about 1,000 computer users at 46 different work
sites in Sweden. The two questions have been qualitatively
validated through interviews of a sample of 50 employees
and proved to be reliable [19]. Strong evidence of a
quantitative link between self-reported presenteeism and
actual productivity loss comes from several studies
involving credit call centre employees in the USA. A
number of objective measures of service representatives’
productivity correlated strongly with the employees’ self
reports [20]. Such self-reported data have been found to be
reliable and valid when the recall periods are short (1–
2 weeks) [32]. The questionnaire also contained two
questions on the receipt of a disability or accident insur-
ance pension as a result of LBP (yes/no; if yes, to what
extent? partial at 25% or 50% or full at 100%). Costs
associated with hours of work lost were calculated using
the respondent’s income before deductions.
In the HC approach we considered all workdays lost due
to absenteeism and presenteeism by individuals engaged in
a salary-paying occupation and due to permanent disability
by individuals of working age. In the FC approach, we
calculated the costs of presenteeism as in the HC approach.
For the costs of absenteeism we assumed that individuals
with absence from work due to LBP were replaced after a
friction period of 22 weeks (as in the study by Boonen
et al. [3] on chronic LBP and other musculoskeletal dis-
eases). Costs of permanent disabilities due to LBP were not
considered in the FC approach.
This calculation was based on the information on
duration of the present LBP episode and the assumption
that an average pain episode will last twice as long as it has
lasted so far. This assumption prevented the underestima-
tion of costs accruing from new LBP episodes (i.e. epi-
sodes that started less than 11 weeks ago) that would
otherwise have occurred due to the retrospective nature of
the survey. Extrapolation of productivity losses to the
whole year considered the inverse probability of capturing
a person with a given length of LBP episode in the survey
(e.g. for a 26-week LBP episode the probability is 26/52 or
1 For further details on the Swiss health care system see European
Observatory on Health Care Systems [17].
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50.0%). Only the productivity lost by employed individuals
was considered. Following Koopmanschap and Rutten [28]
we furthermore assumed that the productivity losses due to
absenteeism were higher for workers with a higher edu-
cation level, as it takes more time to hire and introduce
these workers into the work place (coefficients according to
highest education: 0.8 for basic school, 1.0 for appren-
ticeship or secondary school, and 1.2 for higher education).
This may be a conservative estimate of true production
losses; these losses would be even higher if it is considered
that some of the absent employees work in teams, where
the performance of all team members is affected by the
absence of one of them [34]. Conversely, it may be an
overestimation of production losses if the absence of single
workers is partially absorbed by other team members [28].
Extrapolation of results
Total costs of LBP in Switzerland in 2005 were calculated
with the following procedure2:
(1) Calculation of the yearly cost of LBP for an average
LBP sufferer in Switzerland by multiplying the
estimated average cost per individual with LBP in
the last 4 weeks by 13 (13 multiplied by
4 weeks = 52 weeks).
(2) Calculation of the yearly cost of LBP for an average
individual with or without LBP by multiplying the
yearly cost per LBP sufferer by the prevalence of
LBP in the last 4 weeks according to the baseline
survey in 2003 (24.3%).
(3) Calculation of the total yearly cost of LBP in
Switzerland by multiplying the average yearly cost
of LBP by the size of the reference population in 2005
(5.7 million individuals over the age of 20).
Results
The main questionnaire was sent to a total of 2,860 indi-
viduals over the age of 20 consenting to participate, 2,507
(87.7%) of whom returned it. The prevalence of LBP in the
previous 4 weeks was 50.0% (1,253 individuals over the
age of 20). The duration of the current episode of LBP was
4 weeks or more in 89.1% of the cases.
The weekly pain diary and the bi-monthly cost diary
were sent to a sub-group of 400 individuals consenting to
participate. As much as 305 individuals filled out at least
half of the weekly pain diaries and 201 individuals filled
out at least 5 out of the 6 bi-monthly cost diaries. Unfor-
tunately, the sub-group of the respondents to these two
questionnaires was not large enough to contain a repre-
sentative number of high-cost-generating LBP sufferers.
Our calculation of the costs of LBP is thus entirely based
on the responses to the main questionnaire, and the
responses to the weekly pain diary and the bi-monthly cost
diary were only used to validate these cost estimates and to
determine the average cost of pain medications. Unless
stated otherwise, the results are thus based on the responses
to the main questionnaire.
In comparing the key sociodemographic characteristics of
the individuals with LBP in the last 4 weeks with the cor-
responding values in the Swiss population over the age of 20,
a number of differences emerged: first, our sample covered
only the German-speaking part of Switzerland, where 72.5%
of the total population live [7]. Second, the average age of
individuals with LBP was 2.8 years above the population
average of 49.6 years [10]. Third, the substantial number of
immigrants in Switzerland was most probably underrepre-
sented with only 6.0% of respondents having a foreign
nationality (20.7% in the whole total population [10]).
Fourth, compulsory education was the highest level of
education achieved by just 10.1% of respondents over the
age of 24 (22.8% in the whole population [6]).
Direct costs
The relative use of direct-cost components among
respondents reporting LBP is summarized in Table 1. Pain
medication was the most frequently used resource in the
last 4 weeks with 28.1% of individuals adopting it as their
exclusive treatment or in combination with other treat-
ments. Outpatient medical care was used by 22.8% of
individuals in the last 4 weeks with general practitioner
consultations (11.6%), specialist consultations (6.4%),
physiotherapy (7.6%), and other types of therapy (9.3%)
being the most frequently used resources. Inpatient medical
care was used by 8.6% of individuals in the last 12 months
and included inpatient hospitalization (6.0%), surgery
(4.2%), outpatient hospital visits (2.6%), and stays in a
rehabilitation clinic (2.3%). Self-help was frequent with
22.0% of individuals incurring expenditure for physical
training in the last 12 months and 7.5% for utility devices
in the last 4 weeks. Furthermore, 6.9% of individuals had
relied on a person to assist them in their ADL for an
average of 6.5 h a week.
Figure 1 gives a graphical representation of the per-
centages of LBP sufferers using specified combinations of
2 The extrapolation is based on the assumptions that our sample is
representative for all LBP sufferers in Switzerland and that suffering
from LBP does not vary seasonally. Note that although the sample
covers only the German speaking part of Switzerland, where 72.3% of
the population lives, a large national health survey showed no
significant differences in prevalence of LBP between the language
regions in 2007 (Swiss Federal Office of Statistics [9])
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health care resources or no resources at all. Nearly half of
the individuals suffering from LBP in the last 4 weeks
(48.1%) did not seek any treatment in this time period. Self-
help was important because a part of the expenses incurred
by the 8.8% of LBP sufferers exclusively using pain med-
ication and the 15.5% using only assistance, prevention, or
utility devices is not covered by health insurance.
Average direct costs for an individual reporting LBP in
the last 4 weeks amounted to €1,842 and total direct costs
of LBP in Switzerland amounted to €2.6 billion in 2005
(Table 3). Original prices were in CHF and euro values
were calculated with the mean 2005 exchange rate of
0.646 €/CHF (Swiss National Bank). The most important
direct-cost component was assistance for ADL (18.3% of
direct costs). Physiotherapy (11.2% of direct costs), other
types of therapy (9.3%), visits to the specialist (10.3%),
and the general practitioner (7.5%) also represented
important direct cost components, as did inpatient hospi-
talizations (11.8%) and stays at rehabilitation clinics
(10.6%). Expenditures for utility devices, which may well
have included substantial out-of-pocket expenditures,
amounted to 10.1% of direct costs.
Productivity losses
Table 2 gives an overview of the productivity losses
among the economically active individuals of working age
reporting LBP: 4.4% were absent from work in the last
4 weeks because of LBP, missing an average of 8.2 work
days. LBP-related presenteeism in the last week was
reported by 19.7% respondents (158 of 801 individuals),
corresponding to an average productivity loss of 27.7%.
Permanent disability due to LBP was reported by 3.7% of
respondents receiving a disability pension and 0.6% an
accident insurance pension. The average extent of dis-
ability pension received was 76.7% for disability pensions
and 82.0% for accident insurance pensions. Payments for
disability pensions were not considered in the calculation
of total costs, as they represent a transfer of income and not
a resource consumption.
Productivity losses differed substantially depending on
the method of calculation used (Table 3): average pro-
ductivity loss in association with LBP amounted to €2,926
using the HC approach and just €1,571 using the FC
approach. Productivity losses were dominated by the costs
of presenteeism in both the HC approach (44.1% of total)
and the FC approach (82.2%).
Total costs
Total costs of LBP were calculated as the sum of the total
direct costs (€2.6 billion) and the total productivity losses,
and varied between €6.6 billion (HC approach) and €4.8
billion (FC approach). Productivity losses amounted to
61.4 and 46.0% of these total costs, respectively.
The distribution of costs was highly skewed, with 48.1%
of individuals with LBP in the last 4 weeks reporting no
direct costs and 10% being responsible for 70% of the
direct costs (Fig. 2). The distribution of productivity losses
was even more skewed with 84.3% of individuals having
no costs and 5% being responsible for 73.4% of the pro-
ductivity losses (HC approach).
Breakdown of costs by level of pain
A breakdown of costs of LBP by the level of pain expe-
rienced in the last 4 weeks, on a scale from 0 (no pain) to 6
(unbearable pain), gives important insights into the single
cost categories (Figs. 3, 4). As expected, the number of
LBP sufferers incurring costs, as well as the average
amount of costs, increases in step with the level of pain.
Although direct costs are the most frequent cost category,
up to one-fifth of the individuals with substantial pain do
not cause direct costs (Fig. 3). The percentage of individ-
uals with direct costs increases linearly from 30% at pain
level 1 to 86% at pain level 6. The prevalence of
assistancea,b, preventiona,c and utility devicesa,b
medical care: institutionala,c
medical care: non institutionala,b
no resources usedb
only pain 
medication 
(medical care 
and self care)b
9.0%
48.1%
8.8%
10.0%
2.6%
15.5%
0.9%
2.2%3.0%
Fig. 1 Percentage of LBP
sufferers using specified health
care resources. Total area of
circles corresponds to 100% of
1,253 individuals with LBP in
last 4 weeks. a With and
without use of pain medication;
b in last 4 weeks; c in last
12 months
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individuals with presenteeism increases from 4% at pain
level 1 to 46% at pain level 5 and then decreases to 27% at
pain level 6. This surprising phenomenon can be explained
by the fact that presenteeism represents a point somewhere
in between the continuum from ‘optimal efficiency at
work’ to ‘absence’. On average, individuals with presen-
teeism outnumber the individuals absent from work
because of pain by a factor of 4.5. In the lower pain cat-
egories the individuals working with reduced capacity
outnumber the absentees by a factor between 8 and 12.
However, with higher intensity of pain, the proportion
decreases to 3.5 in pain level 4, to 2.4 in pain level 5 and
\1 in pain level 6. When pain becomes unbearable at
work, the majority will stay at home and the prevalence of
presenteeism diminishes, resulting in a decrease of
presenteeism in relation to absenteeism at higher pain
levels. Absenteeism is marginal at low pain levels, but then
rises from 10% of individuals at pain level 4 to 43% at pain
level 6.
Figure 4 shows the average direct cost and the average
costs of absenteeism and presenteeism according to the HC
approach among the economically active LBP sufferers of
working age. Presenteeism is the most important cost cat-
egory from the moderate pain level of 2 to the high pain
level of 5. Costs of absenteeism are of no importance at
lower pain levels, but substantial at higher pain levels.
Absenteeism replaces presenteeism as the dominant cost
factor only among the small number of individuals with
unbearable pain (0.9% of total).
Sensitivity analysis
An ‘extreme value’ sensitivity analysis was carried out to
verify the robustness of our results [4]. For direct costs we
computed the values delimitating the 95% confidence
interval around the estimated means (±1.96 standard errors
calculated by bootstrapping) of the quantities of direct cost
components and thus calculated a lower bound of total
direct costs of €1.78 billion and an upper bound of
€3.36 billion. Following a similar procedure for produc-
tivity losses, we calculate a lower and upper bound of
€3.32 billion and €4.84 billion for the HC approach and of
€1.67 billion and €2.71 billion for FC approach.
An additional sensitivity analysis of the estimated pro-
ductivity losses appears useful because of the ongoing
debate as to which cost-components should be included in
the calculation and which estimation method used. The
costs of presenteeism, which represent the most important
productivity loss category according to our estimate, have
rarely been assessed in other studies [5, 46]. Respondents
may overestimate the loss of productivity due to LBP if
they take productivity at 100% as the reference value,
which is a level that is seldom achieved at a workplace
even in the total absence of LBP. Under the conservative
Table 2 Productivity losses due to LBP by economically active individuals of working age
Percentage of LBP sufferers
in working age
If yes
Mean SD
Absence due to LBP in last 4 weeks (no. of days) 4.4 8.2 10.7
Impaired productivity at work due to LBP in last week 19.7
Extent of reduction of productivity at work (%)a 27.7 24.0
Duration of current pain episode (no. of days) 16.4 22.9
Up to 7 days 32.7
8–14 days 8.5
15–21 days 4.9
More than 21 days 53.9
Receiving disability pension (IV) 3.7
Extent of disability pension (%)b 76.7 27.8
Number of months since first receiving pension 59.0 73.1
Receiving accident insurance pension (SUVA) 0.6
Extent of accident insurance pension (%)b 82.0 20.5
Number of months since first receiving pension 43.2 32.4
A total of 801 economically active individuals of working age (\64 years for women, \65 years for men)
Lost work hours are valued at gross income before deductions
SUVA Swiss public accident insurance company covering large part of working population, IV Swiss National disability pension which covers
whole population
a Reduction of productivity on a scale from 10 to 100% (interval steps 10, 20, …, 100%)
b Full pension = extent of 100%
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assumption that the actual productivity lost due to pre-
senteeism amounted to only half of the value declared by
respondents, total productivity losses are reduced by 22%
for the HC approach and 41% for the FC approach.
The results of the sensitivity analysis are summarized in
Fig. 5.
Discussion
This study estimated the total cost of LBP in Switzerland
from a societal perspective using a bottom-up prevalence-
based cost-of-illness approach. The findings were based on
a questionnaire completed by a large sample of individuals
Table 3 Total cost of LBP in Switzerland in 2005
Cost per year per
LBP sufferer in €
Total cost LBP in Switzerland
in million €
Percentage of GDP
Total cost with HC approach 4,768 6,648 2.3
Total cost with FC approach 3,413 4,758 1.6
Percentage of direct cost
Total direct cost 1,842 2,568 100.0
Pain medication (medical ? self care) 20 27 1.1
Medical care: outpatient 771 1076 41.9
Visits to general practitioner 138 193 7.5
Visits to specialist 190 264 10.3
Physiotherapy sessions 206 288 11.2
Other therapy sessions 171 238 9.3
MRI examination 42 58 2.3
CT examination 25 35 1.4
Medical care: inpatient 483 674 26.2
Inpatient hospitalization 217 302 11.8
Surgery 26 37 1.4
Outpatient hospital visits 6 9 0.3
Rehabilitation clinic stay 195 271 10.6
Cure stay 39 55 2.1
Assistance, prevention, utility devices 567 791 30.8
Physical training 44 61 2.4
Utility devices 186 260 10.1
Assistance for ADL 337 471 18.3
Percentage of
production losses
Percentage
of total cost
Production losses HC approach 2,926 4,080 100.0 61.4
Absenteeism LBP sufferer 493 688 16.9 10.4
Presenteeism LBP sufferer 1,292 1,801 44.1 27.1
Permanent disability 1,141 1,591 39.0 23.9
Production losses FC approach 1,571 2,190 100.0 46.0
Absenteeism LBP sufferer 279 389 17.8 8.2
Presenteeism LBP sufferer 1,292 1,801 82.2 37.9
Original prices in CHF, € values calculated with mean 2005 exchange rate (0.646 €/CHF, Swiss National Bank)
Population prevalence of LBP according to year 2003 survey by MEM Center of University of Bern: 24.3%
Reference population of individuals over the age of 20 in year 2005: 5,737,935 individuals
Details of cost calculation (absenteeism for FC only if duration of current pain is less than 11 weeks)
absenteeism = daily gross income 9 number of days off work due to LBP in last 4 weeks
presenteeism = gross income per week/number of workdays per week 9 (number of workdays per week - number of absent workdays in
week) 9 degree of work inefficiency for days in current period of pain duration
disability = estimated gross income per week 9 (job workload - disability-adjusted job workload) 9 4
ADL activities of daily living, HC human capital, FC friction cost
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suffering from LBP. Total direct costs were estimated at
€2.6 billion, and productivity losses at €4.1 billion
according to the HC approach and €2.2 billion according to
the FC approach.
Economic and social magnitude of costs
A comparison with the gross domestic product (GDP) and
the total healthcare expenditure is useful to understand the
magnitude of the cost of LBP in Switzerland. Using the HC
approach, the total costs of LBP equated to 2.3% of the
Swiss GDP in 2005; using the FC approach, they amounted
to 1.6% of the GDP. These figures must, however, be
considered with care, as the productivity lost due to LBP
and the value of assistance to individuals affected by LBP
are not considered in the estimation of GDP.
The total healthcare expenditure in Switzerland in 2005
was €33.6 billion or 11.2% of the GDP [8]. Our estimate
of the medical direct costs due to LBP (direct costs
excluding assistance for ADL) was €2.1 billion, which
corresponds to 6.1% of the total healthcare expenditure.
This is a considerable proportion and is comparable to the
relative cost of dental healthcare (6.2% of total), which
represents an important medical expense for many
households.
A considerable share of the direct costs is borne directly
by the patients themselves and their families; the costs of
alternative therapy sessions, expenses for utility devices,
cures and physical training, and assistance provided by
family and friends represent 42.2% of direct costs and are
only partially covered by health insurance or by public
financing. In addition, a substantial part of the expenses for
medical care is paid by patients through co-payments and
deductibles. In 2005, cost participation by the insured
amounted to 14% of total medical expenditures by Swiss
health insurers [8], which implies that an additional 8.2%
of the direct costs of LBP were covered by patients
themselves. Therefore, approximately 45% of the direct
costs of LBP were borne directly by the patients and their
families.3
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3 Calculation share of direct costs sustained directly by patients and
their families: (other therapy sessions ? cure stay ? assistance,
prevention, utility devices) = 42.2% of total direct costs ((expenses
for inpatient and outpatient medical care by health insurance)
multiplied with the average cost participation by the insured
according to national health care statistics) = 8.3% of total direct
costs.
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Plausibility of results
In order to cross-check the plausibility of our direct cost
estimates, we compared our results with national health-
care cost statistics for the year 2005 [8]. In doing so, some
of our direct cost components appeared implausibly large:
our estimate of the costs of physiotherapy sessions were
equivalent to 65.8% of the total corresponding national
expenditure, other therapy sessions to 216.6%, and stays at
a rehabilitation clinic to 54.5%. Our estimate of expendi-
ture for utility devices also appeared very large.
Several factors may be responsible for this discrepancy:
first, our sample may be affected by a self-selection bias as
individuals with more severe LBP and higher resource use
may be more inclined to take the time to respond to the
questionnaire. A similar selection bias was also apparent
when the health care use of the respondents to the main
questionnaire was compared with that of the respondents to
the weekly pain diary. The average proportion of LBP
sufferers seeking physiotherapy sessions was 10.1% in the
last week for the pain diary and 7.6% in the last 4 weeks
for the main questionnaire. Thus, it appears that, in general,
the more demanding the survey, the higher the proportion
of individuals with severe problems (and thus higher costs)
that volunteer to participate.
Second, individuals affected by LBP often seek alter-
native medical therapies which are only partially consid-
ered in the national health cost statistics, as they are
frequently not regulated by health care authorities and their
services are not reimbursed by health insurers. The
respondents to the bi-monthly cost diary reported a total of
100 visits to physiotherapists (144 treatment sessions) and
87 visits to practitioners of alternative medicine (100
treatments) in the past week. As the average cost of an
alternative treatment (€51.8 according to the responses to
the pain dairy) is higher than that of a physiotherapy ses-
sion, the high costs due to other therapy sessions appear
more plausible.
Although recent guidelines recommend the application
of the FC approach (see for example von der Schulenburg
[47]) it is questionable whether this is really the right
approach to apply in Switzerland. The FC approach is based
on the implicit assumption that there is an appreciable level
of unemployment, which ensures that a worker who loses
his job because of LBP will be replaced by someone who
would otherwise have been unemployed. The relatively low
unemployment rate of 3.7% in Switzerland in 2005, the
high labour market participation of 67.0% [6] and the
considerable immigration of workers from EU countries
due to labour shortages tend to violate this assumption.
The breakdown of productivity losses reveals that per-
manent disability leads to high individual costs, but is rel-
atively seldom. On the other hand substantial costs of
presenteeism are mainly due to its relatively high frequency
among individuals reporting LBP. This result confirms the
supposition that presenteeism is of a greater importance
than absenteeism as a cost factor [5, 12, 20, 46].
International comparisons
The societal cost of LBP in Switzerland determined in the
present study appears to be higher than that reported in
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other studies for other countries [14]. However, this is
mainly due to methodological differences between the
studies and the choice of cost-components considered. In
general, top-down COI studies generate much lower cost
estimates as they include considerably fewer cost-category
estimates. The average direct cost of LBP as a percentage
of the GDP in the top-down studies included in the sys-
tematic review of Dagenais et al. [14] was reported to be
just 0.3% while it was 0.9% in our study. Productivity loss
estimates based on the FC approach are also always con-
siderably lower than those calculated using the HC
approach.
When examining only studies that followed a similar
methodology to ours, the extent and composition of costs
appear comparable. A recent study by Wenig et al. [48]
based on a survey of a large sample of German citizens,
estimated the societal costs of LBP to be 2.2% of the
German GDP in 2005, without considering direct costs due
to LBP-sufferers receiving assistance, or presenteeism,
which were both shown to be particularly important in our
study. The cost structure was also similar to that reported in
the present study, with 46% direct costs and 54% produc-
tivity losses (HC approach). A study by Boonen et al. [3]
estimated the cost of chronic LBP at 1.4% of the Dutch
GDP in 2002. Considering that the latter study assessed
productivity losses with the FC approach this estimate
appears to be reasonably in line with our own findings. The
societal costs of LBP in Switzerland appear smaller if
international cost comparisons are carried out with
exchange rates adjusted for purchasing power parity, as the
price level in Switzerland is considerably higher than that
in most other industrial countries.
The peculiarities of the Swiss Healthcare system might
add plausibility to the results as they lead to higher direct
medical costs than in other countries. Under the compul-
sory 100% health insurance coverage for all residents,
patients have free choice in primary and secondary care
and thus the possibility to directly visit a specialist, phys-
iotherapist, or chiropractor without passing through a
gatekeeper, such as the general practitioner or a HMO
organization.
Utility of COI studies
In the last 20 years, several authors, such as Shiell et al.
[42], Currie et al. [13], Drummond [15], Koopmanschap
[26], and others have questioned the value of COI studies
on the basis that they provide no additional information on
the relevance of a given health problem that is not already
contained in medical statistics (e.g. hospital admission,
visits to specialists) and they do not investigate the most
cost-effective measures to cure the disease in question.
However, it should be noted that the assessment of
interventions aimed at prevention or treatment of LBP was
beyond the scope of this study. Our goal was to adopt the
COI methodology in considerable detail and we have made
substantial efforts to collect data not readily available from
national surveys. For instance, we took out-of-pocket
expenditures and direct non-medical costs into account, as
well as productivity losses because of presenteeism.
Despite reservations regarding the theoretical value of the
methodology (a ‘major headache’ according to Drummond
[15]), well-known researchers accept the usefulness of
comprehensive COI studies and international organiza-
tions, such as the OECD and the WHO commonly use this
approach [2, 21, 37]. Furthermore, COI studies often serve
as input for cost-effectiveness analyses [22].
Limitations
Several limitations of this study must be highlighted and
these will be discussed in relation to whether they may
have led to an underestimation or overestimation of costs.
First, the systematic differences between the study
sample and the Swiss target population represent a weak-
ness of the study. While the fact that the survey was limited
to the German-speaking part of Switzerland does not
appear to be too critical—as according to the Swiss Health
Survey 2007 the prevalence of various back problems in
this region (42.2% suffering from various back problems in
the last 4 weeks) lies between the prevalence in the French-
(44.5%) and the Italian-speaking region (41.7%)—the fact
that immigrants were so strikingly underrepresented in the
sample might have serious consequences for the external
validity of the survey. Furthermore, the immigrants who
were included in our sample differed systematically from
the average immigrant, as they possessed a good command
of the German language, a requirement of their participa-
tion in this questionnaire study. Buri et al. [11] found
evidence that individuals with an immigration background
were more likely than native citizens to receive a disability
pension in 2005. This selection bias thus most likely led to
an underestimation of the total costs of LBP in
Switzerland.
Second, individuals were asked if they were willing to
participate in a survey on LBP. It seems plausible that
individuals with more severe LBP would have been more
inclined to volunteer for participation than others, and this
element of self-selection may be expected to contribute to
overestimation of the total costs of LBP. However, a non-
response analysis for a similarly comprehensive survey of
LBP in Germany [38] found only a relatively moderate (1
to 4%) upward bias of the LBP prevalence rate in the
responders. This would have led to an overestimation of the
costs of LBP of between 3.3 and 6.6% [48]. The present
study does not indicate the reasons for non-responders, but
Cost of low back pain in Switzerland 465
123
the high response rate of fully completed questionnaires is
an indicator that overestimation should not be higher than
mentioned above.
Third, we did not consider the higher costs of patients
with private or semi-private insurance in addition to the
compulsory basic insurance. These patients are charged
considerably higher fees for hospital stays and some health
services. As 9.8% of LBP sufferers have private insurance
and 25.4% have semi-private insurance, this is likely to
lead to an underestimation of the total costs of LBP.
Fourth, we did not account for the productivity losses
due to LBP by individuals not belonging to the labour
force, such as household workers, students and pensioners.
This is likely to lead to an underestimation of the total costs
of LBP.
Finally, as discussed in the section on the internal
validity of the questionnaire, some respondents may have
mistakenly reported not only the costs related to LBP, but
also costs due to other illnesses. This may be expected to
lead to an overestimation of the direct costs.
Conclusion
This study elucidates two important components of socio-
economic costs of LBP.
First, a large proportion of the direct costs of LBP are
shouldered by the individuals themselves (approximately
45%). Two out of three individuals suffering from LBP in
the last 4 weeks do not seek any primary care. The distri-
bution of direct costs of LBP is highly skewed to the right.
Half of the individuals use minimal resources, but the
remainder incur substantial out-of-pocket expenditure in
attempting to alleviate their LBP. Although the average
individual expenditure remains low for the majority of
individuals, the high proportion of self-care among the
population has a major impact on the assessment of total
direct costs. In our study we had to rely on self-reported
expenses, which by their very nature are often guessti-
mates. In order to improve the reliability of results, in
future studies the real expense of health-related items
should be assessed—in addition to the use of services
covered by health insurance—by means of an adapted
household-survey.
Second, the evaluation of productivity losses of LBP
reveals that losses due to presenteeism are two to three times
more important than losses due to absenteeism. This result is
independent of the approach adopted to calculate produc-
tivity losses (HC or FC approach). The magnitude of these
losses should motivate employers and policy makers to
improve working conditions for employees with back pain in
order to minimize their loss of productivity. In an age where
all possible avenues for containing health-related losses
must be explored, presenteeism would appear to be one
potential drain on resources that might have been underes-
timated [12, 31]. However, checking through the current
literature, we see that employers seem to be starting to take a
serious look at how the health of their employees affects the
bottom line. There is a need to quantify the loss of production
from the employer’s point of view. Studies should be carried
out to examine the extent to which employer-sponsored
health management interventions can minimize the loss of
productivity associated with LBP and whether there is
enough return on investment to warrant action. In order to
improve the reliability of results, worker productivity
instruments should be applied to assess presenteeism [32]
and easy-to-use questionnaires should be developed to
determine how employee presenteeism affects profit.
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